Mezzaroba, N
13  Ergebnisse:
Personensuche X
?
 
?
4

5.58 Advances in the Use of Targeted Nanoparticles for the ..:

Mansilla, E. ; Marín, G.H. ; Roque, G....
Clinical Lymphoma Myeloma and Leukemia.  11 (2011)  - p. S284 , 2011
 
?
5

Development of human bispecific antibodies against CD20/CD5..:

Macor, P. ; Secco, E. ; Mezzaroba, N....
Molecular Immunology.  47 (2010)  13 - p. 2287-2287 , 2010
 
?
6

Recruitment of human endothelial cells expressing alpha-gal..:

Macor, P. ; Mezzaroba, N. ; Bossi, F....
Molecular Immunology.  47 (2010)  13 - p. 2287-2288 , 2010
 
?
7

A new approach for the treatment of CLL using chlorambucil/..:

Capolla, S ; Mezzaroba, N ; Zorzet, S...
info:eu-repo/semantics/altIdentifier/wos/WOS:000371798800026.  , 2016
 
?
8

New potential therapeutic approach for the treatment of B-C..:

Mezzaroba, N ; Zorzet, S ; Secco, E...
info:eu-repo/semantics/altIdentifier/pmid/24098639.  , 2013
 
?
 
?
11

Antiulcerative properties of bovine α-lactalbumin:

Mezzaroba, L.F.H. ; Carvalho, J.E. ; Ponezi, A.N....
International Dairy Journal.  16 (2006)  9 - p. 1005-1012 , 2006
 
?
12

Rationale, study design, and analysis plan of the Alveolar ..:

Cavalcanti, AB ; Berwanger, O ; Suzumura, ÉA...
info:eu-repo/semantics/altIdentifier/wos/WOS:000314100100001.  , 2012
 
?
13

Effect of lung recruitment and titrated Positive End-Expira..:

Cavalcanti A. B ; Suzumura E. A ; Laranjeira L. N...
info:eu-repo/semantics/altIdentifier/wos/WOS:000412838900017.  , 2017
 
1-13